Universal Informatics · Research reading room

Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial

Hoge EA, Bui E, Mete M, Dutton MA, Baker AW, Simon NM. · JAMA psychiatry · 2023 · Randomized controlled trial; single-blind (clinical assessors)

Original publication · Original publication · Original publication

Recorded summary

MBSR met the prespecified noninferiority criterion against escitalopram for anxiety severity at eight weeks. Mean CGI-S improvement was 1.35 points with MBSR and 1.43 with escitalopram.

Recorded limitations

This result applies to a structured, teacher-led MBSR course and the trial’s noninferiority margin. It is not a test of an app or gene expression.

Evidence and provenance

Chapter Trust Factor uses a minimum of three distinct qualifying studies. Publication records retain their own evidence and assessment.

Study design and assessment
design
Randomized controlled trial; single-blind (clinical assessors)
assessment
basis
The article identifies a single-blind trial: independent clinical evaluators were masked, while participants and providers knew the treatment.
sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC9647561/ · https://pubmed.ncbi.nlm.nih.gov/36350591/ · https://doi.org/10.1001/jamapsychiatry.2022.3679 · https://clinicaltrials.gov/study/NCT03522844

assessed At
2026-10-23
registered Masking Basis
false
category
single-blind-rct
peer Reviewed
true
trust Factor
score
2
scope
Paper
status
assessed
randomized Controlled Trial
true
blinding
single
peer Reviewed
true
basis
The article identifies a single-blind trial: independent clinical evaluators were masked, while participants and providers knew the treatment.
sources

https://pubmed.ncbi.nlm.nih.gov/36350591/ · https://pmc.ncbi.nlm.nih.gov/articles/PMC9647561/ · https://doi.org/10.1001/jamapsychiatry.2022.3679 · https://clinicaltrials.gov/study/NCT03522844

review Scope
Existing publication-specific assessments and bibliographic indexing; no blanket full-text appraisal.
assessed At
2026-10-27
jadad
status
unassessed
score
Not recorded
evidence
intervention
MBSR
comparator
Escitalopram
sample
276 adults randomized; 208 in the primary per-protocol analysis
measurement
Clinician-rated anxiety severity
timing
8-week primary endpoint; follow-up to 24 weeks
trial Id
NCT03522844
measured Genes
None recorded
pathways
None recorded
evidence Type
Clinical outcomes
source URLs

https://pmc.ncbi.nlm.nih.gov/articles/PMC9647561/ · https://pubmed.ncbi.nlm.nih.gov/36350591/ · https://doi.org/10.1001/jamapsychiatry.2022.3679

checked At
2026-10-23
review Scope
Publication abstract and selected full-text methods; Jadad assessment pending
Topics and recorded topic scores
  1. key
    language:mindfulness-clinical
    title
    Mindfulness-based interventions: controlled clinical trials
    collection
    language
    trust Score
    2
Citation snapshot and identifiers
id
pmid-36350591
doi
10.1001/jamapsychiatry.2022.3679
pmid
36350591
citation Snapshot
count
184
source
Crossref
retrieved At
2026-10-23
url
https://api.crossref.org/works/10.1001/jamapsychiatry.2022.3679
citations By Collection
language
184
Complete approved library record
id
pmid-36350591
aliases
None recorded
title
Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial
journal
JAMA psychiatry
neurotransmitters
None recorded
year
2023
authors
Hoge EA, Bui E, Mete M, Dutton MA, Baker AW, Simon NM.
design
Randomized controlled trial; single-blind (clinical assessors)
identity Conflict
Not recorded
doi
10.1001/jamapsychiatry.2022.3679
pmid
36350591
urls

https://pmc.ncbi.nlm.nih.gov/articles/PMC9647561/ · https://pubmed.ncbi.nlm.nih.gov/36350591/ · https://doi.org/10.1001/jamapsychiatry.2022.3679

collections

language

categories

Clinical & self-report

targets
None recorded
priority
1
quotes
None recorded
summary
MBSR met the prespecified noninferiority criterion against escitalopram for anxiety severity at eight weeks. Mean CGI-S improvement was 1.35 points with MBSR and 1.43 with escitalopram.
limitation
This result applies to a structured, teacher-led MBSR course and the trial’s noninferiority margin. It is not a test of an app or gene expression.
citation Count
184
citation Snapshot
count
184
source
Crossref
retrieved At
2026-10-23
url
https://api.crossref.org/works/10.1001/jamapsychiatry.2022.3679
study Design Assessment
basis
The article identifies a single-blind trial: independent clinical evaluators were masked, while participants and providers knew the treatment.
sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC9647561/ · https://pubmed.ncbi.nlm.nih.gov/36350591/ · https://doi.org/10.1001/jamapsychiatry.2022.3679 · https://clinicaltrials.gov/study/NCT03522844

assessed At
2026-10-23
registered Masking Basis
false
category
single-blind-rct
peer Reviewed
true
paper Trust Assessment
score
2
scope
Paper
status
assessed
randomized Controlled Trial
true
blinding
single
peer Reviewed
true
basis
The article identifies a single-blind trial: independent clinical evaluators were masked, while participants and providers knew the treatment.
sources

https://pubmed.ncbi.nlm.nih.gov/36350591/ · https://pmc.ncbi.nlm.nih.gov/articles/PMC9647561/ · https://doi.org/10.1001/jamapsychiatry.2022.3679 · https://clinicaltrials.gov/study/NCT03522844

review Scope
Existing publication-specific assessments and bibliographic indexing; no blanket full-text appraisal.
assessed At
2026-10-27
citations By Collection
language
184
topics
  1. key
    language:mindfulness-clinical
    title
    Mindfulness-based interventions: controlled clinical trials
    collection
    language
    trust Score
    2
journal Key
jamapsychiatry
journal Label
JAMA psychiatry
chapter Entries
  1. id
    language-mindfulness-clinical-pmid-36350591
    record Id
    pmid-36350591
    title
    Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial
    journal
    JAMA psychiatry
    year
    2023
    authors
    Hoge EA, Bui E, Mete M, Dutton MA, Baker AW, Simon NM.
    design
    Randomized controlled trial; single-blind (clinical assessors)
    urls

    https://pmc.ncbi.nlm.nih.gov/articles/PMC9647561/ · https://pubmed.ncbi.nlm.nih.gov/36350591/ · https://doi.org/10.1001/jamapsychiatry.2022.3679

    quotes
    None recorded
    summary
    MBSR met the prespecified noninferiority criterion against escitalopram for anxiety severity at eight weeks. Mean CGI-S improvement was 1.35 points with MBSR and 1.43 with escitalopram.
    limitation
    This result applies to a structured, teacher-led MBSR course and the trial’s noninferiority margin. It is not a test of an app or gene expression.
    citation Count
    184
    citation Snapshot
    count
    184
    source
    Crossref
    retrieved At
    2026-10-23
    url
    https://api.crossref.org/works/10.1001/jamapsychiatry.2022.3679
    study Design Assessment
    basis
    The article identifies a single-blind trial: independent clinical evaluators were masked, while participants and providers knew the treatment.
    sources

    https://pmc.ncbi.nlm.nih.gov/articles/PMC9647561/ · https://pubmed.ncbi.nlm.nih.gov/36350591/ · https://doi.org/10.1001/jamapsychiatry.2022.3679 · https://clinicaltrials.gov/study/NCT03522844

    assessed At
    2026-10-23
    registered Masking Basis
    false
    category
    single-blind-rct
    peer Reviewed
    true
    source Pages
    None recorded
    targets
    None recorded
    categories

    Clinical & self-report

    doi
    10.1001/jamapsychiatry.2022.3679
    pmid
    36350591
    evidence
    intervention
    MBSR
    comparator
    Escitalopram
    sample
    276 adults randomized; 208 in the primary per-protocol analysis
    measurement
    Clinician-rated anxiety severity
    timing
    8-week primary endpoint; follow-up to 24 weeks
    trial Id
    NCT03522844
    measured Genes
    None recorded
    pathways
    None recorded
    evidence Type
    Clinical outcomes
    source URLs

    https://pmc.ncbi.nlm.nih.gov/articles/PMC9647561/ · https://pubmed.ncbi.nlm.nih.gov/36350591/ · https://doi.org/10.1001/jamapsychiatry.2022.3679

    checked At
    2026-10-23
    review Scope
    Publication abstract and selected full-text methods; Jadad assessment pending
    paper Trust Assessment
    score
    2
    scope
    Paper
    status
    assessed
    randomized Controlled Trial
    true
    blinding
    single
    peer Reviewed
    true
    basis
    The article identifies a single-blind trial: independent clinical evaluators were masked, while participants and providers knew the treatment.
    sources

    https://pubmed.ncbi.nlm.nih.gov/36350591/ · https://pmc.ncbi.nlm.nih.gov/articles/PMC9647561/ · https://doi.org/10.1001/jamapsychiatry.2022.3679 · https://clinicaltrials.gov/study/NCT03522844

    review Scope
    Existing publication-specific assessments and bibliographic indexing; no blanket full-text appraisal.
    assessed At
    2026-10-27
    collection
    language
    chapter Number
    4
    topic Id
    mindfulness-clinical
    topic Title
    Mindfulness-based interventions: controlled clinical trials
    trust Score
    2
evidence
intervention
MBSR
comparator
Escitalopram
sample
276 adults randomized; 208 in the primary per-protocol analysis
measurement
Clinician-rated anxiety severity
timing
8-week primary endpoint; follow-up to 24 weeks
trial Id
NCT03522844
measured Genes
None recorded
pathways
None recorded
evidence Type
Clinical outcomes
source URLs

https://pmc.ncbi.nlm.nih.gov/articles/PMC9647561/ · https://pubmed.ncbi.nlm.nih.gov/36350591/ · https://doi.org/10.1001/jamapsychiatry.2022.3679

checked At
2026-10-23
review Scope
Publication abstract and selected full-text methods; Jadad assessment pending
jadad
status
unassessed
score
Not recorded
condition Evidence
  1. id
    anxiety
    evidence
    1. field
      title
      text
      Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial
      matched Text
      Anxiety
    2. field
      evidence.measurement
      text
      Clinician-rated anxiety severity
      matched Text
      anxiety
conditions

anxiety

topic Trust Scores

2

full Text
status
not-indexed
retrieval Available
false

Open this publication in the interactive library